Measuring lupus arthritis activity using contrasted high-field MRI. Associations with clinical measures of disease activity and novel patterns of disease
10.1136/lupus-2018-000264
July 26, 2018
Biomarker Studies
TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
10.1136/lupus-2018-000260
June 4, 2018
Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
10.1136/lupus-2018-000263
May 23, 2018
Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection
10.1136/lupus-2016-000159
November 10, 2016
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus
10.1136/lupus-2016-000165
September 30, 2016
Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation
10.1136/lupus-2016-000162
August 16, 2016
Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE
10.1136/lupus-2015-000107
June 20, 2016
Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus
10.1136/lupus-2016-000148
April 29, 2016
Characterisation of an epigenetically altered CD4+ CD28+ Kir+ T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry
10.1136/lupus-2016-000147
April 4, 2016
Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products
10.1136/lupus-2015-000127
February 1, 2016